These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
399 related items for PubMed ID: 21954268
21. MMR vaccination and disease elimination: the Finnish experience. Davidkin I, Kontio M, Paunio M, Peltola H. Expert Rev Vaccines; 2010 Sep; 9(9):1045-53. PubMed ID: 20822347 [Abstract] [Full Text] [Related]
22. Progress toward elimination of rubella and congenital rubella syndrome--the Americas, 2003-2008. Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep; 2008 Oct 31; 57(43):1176-9. PubMed ID: 18971920 [Abstract] [Full Text] [Related]
23. Rubella outbreaks following virus importations: the experience of Chile. Gallegos D, Olea A, Sotomayor V, González C, Muñoz JC, Ramos M, Espinoza MC, Mendoza G, Torres G, Espiñeira E, Andrade W, Fernández J, Fasce R. J Infect Dis; 2011 Sep 01; 204 Suppl 2():S669-74. PubMed ID: 21954265 [Abstract] [Full Text] [Related]
24. Evaluation of immunity against rubella in Iranian after mass campaign for measles-rubella vaccination on December 2003. Hamkar R, Jalilvand S, Mokhtari-Azad T, Jelyani KN, Nategh R. Am J Infect Control; 2006 Nov 01; 34(9):588-92. PubMed ID: 17097454 [Abstract] [Full Text] [Related]
25. The use of rapid coverage monitoring in the national rubella vaccination campaign, Haiti 2007-2008. Lacapère F, Magloire R, Danovaro-Holliday MC, Flannery B, Chamoulliet H, Celestin EP. J Infect Dis; 2011 Sep 01; 204 Suppl 2():S698-705. PubMed ID: 21954269 [Abstract] [Full Text] [Related]
29. Evidence used to support the achievement and maintenance of elimination of rubella and congenital rubella syndrome in the United States. Reef SE, Redd SB, Abernathy E, Kutty P, Icenogle JP. J Infect Dis; 2011 Sep 01; 204 Suppl 2():S593-7. PubMed ID: 21954252 [Abstract] [Full Text] [Related]
31. Progress toward measles elimination in Romania after a mass vaccination campaign and implementation of enhanced measles surveillance. Pistol A, Hennessey K, Pitigoi D, Ion-Nedelcu N, Lupulescu E, Walls L, Bellini W, Strebel P. J Infect Dis; 2003 May 15; 187 Suppl 1():S217-22. PubMed ID: 12721916 [Abstract] [Full Text] [Related]
33. Investigation of a rubella outbreak in Kyrgyzstan in 2001: implications for an integrated approach to measles elimination and prevention of congenital rubella syndrome. Dayan GH, Zimmerman L, Shteinke L, Kasymbekova K, Uzicanin A, Strebel P, Reef S. J Infect Dis; 2003 May 15; 187 Suppl 1():S235-40. PubMed ID: 12721919 [Abstract] [Full Text] [Related]
39. When, and how, should we introduce a combination measles-mumps-rubella (MMR) vaccine into the national childhood expanded immunization programme in South Africa? Cameron NA. Vaccine; 2012 Sep 07; 30 Suppl 3():C58-60. PubMed ID: 22939023 [Abstract] [Full Text] [Related]